TISSUE-SPECIFIC EXPRESSION OF THE HLA-DRA GENE IN TRANSGENIC MICE

被引:12
作者
GIACOMINI, P
CIUCCI, A
NICOTRA, MR
NASTRUZZI, C
FERIOTTO, G
APPELLA, E
GAMBARI, R
POZZI, L
NATALI, PG
机构
[1] CNR, INST BIOMED TECHNOL, ROME, ITALY
[2] BIOTECHNOL CTR, BIOCHEM LAB, FERRARA, ITALY
[3] NIH, CELL BIOL LAB, BETHESDA, MD 20892 USA
[4] UNIV ROME LA SAPIENZA, DEPT BIOPATHOL, I-00185 ROME, ITALY
关键词
D O I
10.1007/BF01787489
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Transgenic mice were produced containing a 33 kilobase (kb) DNA fragment encompassing the five exons and all the known regulatory regions of the class II HLA-DRA gene. The transgene displayed regulated expression [constitutive and interferon-gamma (IFN)-gamma induced] of the human products in most mouse tissues. The tissue distribution of the DRA transgene products more closely resembled that of their mouse homologues, the endogenous H-2 Ea products, than the wider distribution of DRA products in humans. This was evident in several tissues (endothelia of small vessels, especially those of glomerular capillaries, Kupffer cells, and epithelial cells lining the gastrointestinal tract), known to differentially express class II molecules in the two species. Thus, the wider human specific pattern of expression requires an exact cis/trans complementation which is incompletely reconstituted in transgenic mice, suggesting that human-specific cis-acting elements may have arisen during evolution to direct the expression of class II genes to those anatomical regions which usually lack them in the mouse. The only example of aberrant expression of the DRA gene in the present series of transgenic mice was in the dendritic and/or epithelial cells of the thymic cortex, which displayed greatly reduced DR-alpha-levels in spite of a normal expression of the endogenous E-alpha-molecules.
引用
收藏
页码:385 / 391
页数:7
相关论文
共 33 条
  • [1] ADAMS TE, 1983, IMMUNOLOGY, V50, P613
  • [2] FUNCTIONAL EXPRESSION OF A HETEROLOGOUS MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENE IN TRANSGENIC MICE
    BIEBERICH, C
    YOSHIOKA, T
    TANAKA, K
    JAY, G
    SCANGOS, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (11) : 4003 - 4009
  • [3] BOTTAZZO GF, 1983, LANCET, V2, P1115
  • [4] BRADLEY LM, 1980, SELECTED METHODS CEL, P162
  • [5] AN EMBRYONIC PATTERN OF EXPRESSION OF A HUMAN-FETAL GLOBIN GENE IN TRANSGENIC MICE
    CHADA, K
    MAGRAM, J
    COSTANTINI, F
    [J]. NATURE, 1986, 319 (6055) : 685 - 689
  • [6] TISSUE-SPECIFIC AND CELL-SURFACE EXPRESSION OF HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I HEAVY (HLA-B7) AND LIGHT (BETA-2-MICROGLOBULIN) CHAIN GENES IN TRANSGENIC MICE
    CHAMBERLAIN, JW
    NOLAN, JA
    CONRAD, PJ
    VASAVADA, HA
    VASAVADA, HH
    GANGULY, S
    JANEWAY, CA
    WEISSMAN, SM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) : 7690 - 7694
  • [7] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [8] DOES T-CELL RESTRICTION TO IA LIMIT THE NEED FOR SELF-TOLERANCE
    COWING, C
    [J]. IMMUNOLOGY TODAY, 1985, 6 (03): : 72 - 74
  • [9] B-CELL CONTROL REGION AT THE 5' END OF A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE - SEQUENCES AND FACTORS
    DORN, A
    FEHLING, HJ
    KOCH, W
    LEMEUR, M
    GERLINGER, P
    BENOIST, C
    MATHIS, D
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (10) : 3975 - 3987
  • [10] EXPRESSION OF A CLASS-I MHC TRANSGENE - EFFECTS OF INVIVO ALPHA/BETA-INTERFERON TREATMENT
    EHRLICH, R
    SHARROW, SO
    MAGUIRE, JE
    SINGER, DS
    [J]. IMMUNOGENETICS, 1989, 30 (01) : 18 - 26